Children's cancers, Liver cancer
Results
Phase 2
This trial looked at irinotecan for children and young people with hepatoblastoma that had continued to grow or come back after treatment.
Recruitment start: 1 April 2003
Recruitment end: 31 December 2008
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Penelope Brock
Cancer Research UK
Children's Cancer and Leukaemia Group (CCLG)
Experimental Cancer Medicine Centre (ECMC)
National Institute for Health Research Cancer Research Network (NCRN)
Last reviewed: 15 October 2013
CRUK internal database number: 281